BIO vs COLB · rev $2.58B vs P/E 12, rev $148.8M
BIO (BIO) versus Columbia Banking System Inc (COLB) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Columbia Banking System Inc (COLB) is a banks - regional company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported COLB revenue for 2024-12-31 was $148.8M. Net income was $533.7M. Revenue was up 10.8% from 2023-12-31 to 2024-12-31. COLB currently screens at market cap $8.58B and trailing P/E 11.6.
BIO currently screens at market cap $0. COLB currently screens at market cap $8.58B and trailing P/E 11.6.
Not investment advice. Open the BIO and COLB stock pages for the full models.
Not investment advice.